The latest news in cancer research, health and policy by Cancer Research UK.
We cover developments in cancer treatments, research into cancer risk and diagnosis as well as the latest cancer science stories. You'll also find analysis and comment on health and cancer policy.
US researchers have found a link between the makeup of bacteria in the tumours of people with pancreatic cancer and how long they live.
A dual kinase inhibitor is entering a clinical trial for advanced pancreatic cancer in combination with gemcitabine.
A drug that’s designed to target weaknesses inside cancer cells can hold some advanced pancreatic cancers at bay for a short time after chemotherapy.
Scientists have found a new way in which cells that surround pancreatic cancers in mice can help the tumours grow.
Researchers have launched a clinical trial to develop a breath test, analysing molecules that could indicate the presence of cancer at an early stage.
Scientists in Liverpool have been awarded £2.17 million by Cancer Research UK to develop ways to spot pancreatic cancer earlier.
A combination of chemotherapy drugs was better than a single drug at extending the lives of pancreatic cancer patients after surgery.
Pancreatic cancer patients treated with chemotherapy and radiotherapy before surgery may live longer than those who have immediate surgery.
Doctors should use a specialised type of scan to help decide if patients with pancreatic cancer may benefit from surgery, according to NICE.
Two important cancer genes cooperate to make lung cancers more aggressive in mice, according to new research.